Amdocs (DOX) Reports In-Line Q4 EPS, Offers Q1 Guidance

Amdocs (NASDAQ: DOX) reported Q4 EPS of $0.99, in-line with the analyst estimate of $0.99. Revenue for the quarter came in at $1 billion versus the consensus estimate of $1 billion.

GUIDANCE:

Amdocs sees Q1 2019 EPS of $0.95-$1.01, versus the consensus of $1.06. Amdocs sees Q1 2019 revenue of $990-1030 million, versus the consensus of $1.02 million.

Full Year Fiscal 2019 Outlook

• Revenue growth of 1.0%-5.0% year-over-year
• Revenue growth of 2.0%-6.0% year-over-year on a constant currency basis
• Full year fiscal 2019 revenue guidance incorporates an expected negative impact from foreign currency fluctuations of about 1.0% year-over-year
• GAAP diluted earnings per share growth of roughly 29.0%-38.0% year-over-year
• Non-GAAP diluted earnings per share growth of roughly 3.0%-7.0% year-over-year, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately $0.22-$0.30 per share of equity-based compensation expense, net of related tax effects

For earnings history and earnings-related data on Amdocs (DOX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Pfizer lung cancer drug misses survival goal in Phase 3 trial